Pediatrix Medical Group Cash Flow Statement
NYSE: MDHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pediatrix Medical Group free cash flow
In fiscal 2025, Pediatrix Medical Group generated $271.1 million of operating cash flow and spent $18.5 million on capital expenditures. That left free cash flow of $252.6 million, a free-cash-flow margin of 13.2% of revenue. Free cash flow was up 36.9% from the prior year's $184.6 million.
Pediatrix Medical Group returned $86.7 million to shareholders through share repurchases, equal to 34% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Pediatrix Medical Group cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 165.39M | -99.07M | -60.41M | 66.33M | 130.94M | -796.49M | -1.50B | 268.63M | 320.37M | 324.60M |
| Net Income growth (YoY) | — | — | -191.07% | -49.34% | — | — | -657.54% | -16.15% | -1.30% | -3.31% |
| Depreciation & Amortization | 21.83M | 32.23M | 36.17M | 35.64M | 32.15M | 28.44M | 25.93M | 24.36M | 78.86M | 89.26M |
| Stock-Based Compensation | 18.05M | 11.87M | 12.32M | 16.13M | 18.97M | 39.04M | 33.41M | 36.59M | 28.78M | 34.00M |
| Change in Working Capital | 29.90M | 42.24M | -13.64M | -9.19M | -32.40M | 41.41M | 2.62M | -19.60M | 41.96M | -30.57M |
| Operating Cash Flow | 271.09M | 206.57M | 137.32M | 166.94M | 76.74M | 204.62M | 357.71M | 313.71M | 511.38M | 443.78M |
| Capital Expenditures | -18.46M | -22.02M | -33.33M | -29.71M | -32.25M | -28.79M | -19.27M | -17.12M | -26.15M | -39.26M |
| Investing Cash Flow | -18.30M | -35.41M | -48.18M | -56.95M | -53.07M | 815.51M | 102.45M | -142.77M | -576.61M | -821.22M |
| Share Repurchases | -86.68M | -1.70M | -919.00K | -88.51M | -4.72M | -8.49M | -145.28M | -302.16M | -70.19M | -61.83M |
| Debt Issued | — | 0 | 0 | 650.00M | 0 | 0 | 500.00M | 500.00M | 0 | — |
| Debt Repaid | — | 0 | 0 | -1.05B | -759.85M | 0 | — | — | — | — |
| Financing Cash Flow | -107.49M | -14.48M | -25.71M | -487.55M | -760.12M | -4.16M | -393.07M | -170.61M | 89.74M | 381.56M |
| Net Change in Cash | 145.30M | 156.68M | 63.43M | -377.57M | -736.45M | 1.02B | 67.10M | 329.00K | 24.50M | 4.13M |
| Free Cash Flow | 252.63M | 184.55M | 104.00M | 137.23M | 44.49M | 175.83M | 338.44M | 296.59M | 485.23M | 404.51M |
This table shows 10 annual periods of Pediatrix Medical Group's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MD's reporting calendar. What is a cash flow statement?